Baar MP, Brandt RMC, Putavet DA, Klein JDD, Derks KWJ, Bourgeois BRM, Stryeck S, Rijksen Y, van Willigenburg H, Feijtel DA, van der Pluijm I, Essers J, van Cappellen WA, van IJcken WF, Houtsmuller AB, Pothof J, de Bruin RWF, Madl T, Hoeijmakers JHJ, Campisi J, de Keizer PLJ
Access to providers for dose adjustments, side effect management, and ongoing monitoring contributes to treatment safety and effectiveness
In this case, your provider will determine if they are right for you based on your health profile
Finally, rosiglitazone increased the expression of thyroid-specific differentiation markers ( in vitro study, under normoxic or hypoxic conditions, it was reported that rosiglitazone inhibited TC cell growth and increased NIS protein expression
10.1016/j.neuron.2009.01.034 Neuron 24 BowmanR
Differences between treatment groups were identified using simple main effect test (a) and ANOVA with Bonferroni post-hoc test (b)